Ezetimibe (Prasco Laboratories)
Welcome to the PulseAid listing for the Ezetimibe drug offered from Prasco Laboratories. This Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Prasco Laboratories |
NON-PROPRIETARY NAME: | Ezetimibe |
SUBSTANCE NAME: | EZETIMIBE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2017-05-22 |
END MARKETING DATE: | 0000-00-00 |
Ezetimibe HUMAN PRESCRIPTION DRUG Details:
Item Description | Ezetimibe from Prasco Laboratories |
LABELER NAME: | Prasco Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2017-05-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66993-483_3d639508-1a4d-4099-98b9-ad9122ebfb7c |
PRODUCT NDC: | 66993-483 |
APPLICATION NUMBER: | NDA021445 |
Other EZETIMIBE Pharmaceutical Manufacturers / Labelers: